Mihai Manolache is the founder of CEBIS International and holds a PhD in Biostatistics, “Carol Davila” University of Medicine and Pharmacy, Bucharest, and a Master’s Degree in Biostatistics, the University of Bucharest, Romania. Mihai completed a post-graduate course in immunology and genetics, HMX – Harvard Medical School, graduated from Law School, specializing in Medical Research Law and Regulations, and graduated from Economics, specializing in Administrative Sciences, from the University of Bucharest. Mihai also holds a PG in Clinical Trials Management. Mihai has expertise in planning, managing and coordinating clinical studies globally. He has directed more than 200 international clinical studies including managing research sites across Romania, Bulgaria, Croatia, Hungary, Serbia and Montenegro, Macedonia,Moldova, Greece, Turkey, India, Spain, Switzerland, Italy, Germany, Ukraine, Estonia, Latvia, and Lithuania. Mihai has managed clinical trials in a variety of therapeutic areas including cardiology, oncology, diabetes, CNS, hematology, urology, gastroenterology, pediatrics, HIV, immunology, ObGyn, respiratory, and dermatology. Prior to the formation of CEBIS, Mihai was the Clinical Operations and Business Development Manager for a Global US-Based Contract Research Organization, responsible for setting up and developing clinical research business in the EMEA region.
Message from the CEO
At CEBIS International we keep our focus on what the patient needs. Our patient centric approach permeates throughout all our services, whether it is clinical research or our very own patient support programs.
At CEBIS, we help patients access novelty treatments, whether these treatments are in the development phase, or in a post-marketing setting. We understand innovative and high-tech therapies can save a patient’s life, and we have the ability to make a significant and positive impact in improving the quality of a patient’s life. We offer a unique and tailored solution, combined with a technology approach, to help identify and support patients access and adhere to a particular therapy or device. We accomplish this by working as part of the clinical team, advancing medical science and research, and advocating and supporting patients throughout their treatment journey. We constantly strive to improve our processes to ultimately optimize patient outcomes.
Our mission is to actively help patients obtain a correct diagnosis, access the best available treatment and support, to ensure high adherence for optimal clinical results and quality outcomes.
